Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

IFPMA Launches Ten Principles on Counterfeit Medicines

By Drug Discovery Trends Editor | June 24, 2010

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launched its Ten Principles on Counterfeit Medicines, to re-focus attention on this issue and underline the R&D-based pharmaceutical industry’s stance in the global fight against counterfeit medicines.

Mr Haruo Naito, President of the IFPMA, and President and CEO of Eisai, commented: “Counterfeit medicines are a crime, and our industry is serious about tackling this problem head on. These criminals pose a threat to global public health: deliberately and deceitfully they attempt to pass off their dangerous products as legitimate medicines, and risk patients’ lives in order to make illegal profits. This is not about commercial interest; this is about protecting patients, and we stand ready to be an active partner in WHO-led efforts, including IMPACT.”

Data gathered by the industry’s Pharmaceutical Security Institute (PSI) shows that the scope of the problem and the number of incidents is on the rise. Speaking in support of the IFPMA Principles, Mr. Thomas T. Kubic, CEO of PSI, said:  “Based on our research, the number of counterfeit medicine incidents worldwide rose almost seven percent last year, to 1,693.  Of particular concern has been the growth in counterfeit anti-infectives. In 2009, incidents involving counterfeit anti-infectives increased by almost 50% over the previous year. Anti-infectives, which include anti-malarials, are the therapeutic category most affected by counterfeiting incidents in Africa. Moreover, criminal gangs engaged in the manufacture, distribution and sale of counterfeit medicines are now copying other life-saving treatments including cancer therapies and heart disease medicines.”

Despite counterfeiting being identified as a public health threat by many governments, there is still lack of awareness among policy makers and the general public about the real consequences of this criminal activity and the scope of action that is needed. Developing countries are particularly at risk, given their varying degrees of awareness and limited resources for effective enforcement.

Eduardo Pisani, Director General of the IFPMA, commented: “We hope that the Ten Principles will highlight the full scope of the problem and demonstrate that the fight against counterfeit medicines is simply about protecting patients’ health. The IFPMA calls on all stakeholders, including governments, health care providers, patients, the private sector and the WHO, to take collaborative action and create a global policy environment that recognizes, prioritizes and effectively addresses this major threat to global health.”

Date: June 12, 2010
Source: International Federation of Pharmaceutical Manufacturers & Associations


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE